Vaccines, Conjugate
-
Subject Areas on Research
- Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older--United States, 2015.
- Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
- Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.
- Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana.
- Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
- Hepatitis B vaccination and booster in predialysis patients: a 4-year analysis.
- Immunogenicity and safety of the quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in splenectomized or hyposplenic children and adolescents: Results of a phase III, open, non-randomized study.
- Immunogenicity of Haemophilus influenzae type b protein conjugate vaccines in very low birth weight infants.
- Meningococcal immunisation in Ghana.
- Missed Opportunities for Human Papillomavirus Vaccine Initiation in an Insured Adolescent Female Population.
- Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations.
- Pneumococcal Carriage and Vaccine Coverage in Retirement Community Residents.
- Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination.
- The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.
- Vi-specific serological correlates of protection for typhoid fever.